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The effect of I2-O-tetradeeanoylphorbol-13-acetate (TPA) on serotonin-induced inositol phosphate (IP) accumulation 
and intracellular free Ca*+ concentrations ([C$+],) was investigated in cultured rat vascular smooth muscle cells. Pretreat- 
ment with TPA had no effect on basal levels of both IP production and [Ca2’],, whereas it significantly attenuated seroton- 
in-induced increases in both IP production and [Ca2’],. These data suggest that protein kinase C is involved in the negative 
feedback control ofserotonin-induced rises in both IP production and [Ca*‘],. 
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1. INTRODUCTION 
Since Page [l] unravelled the chemistry of 
serotonin or 5-hydroxytryptamine (5HT), a varie- 
ty of its actions on blood vessels have been the sub- 
ject of intensive research. It has been reported that 
5-HT has a direct vasoconstrictive ffect through a 
5-HT2 receptor recognition mechanism [2]. After 
binding to its specific receptors on vascular smooth 
muscle cells (VSMCs), inositol, 1,4,5_trisphos- 
phate (IPJ), a product of the hydrolysis of the 
plasma membrane phosphatidylinositol 4,5-bis- 
phosphate (PIP2) by phospholipase C, appears to 
act as a second messenger to release Ca2+ from in- 
tracellular store sites in VSMCs [3]. This receptor- 
linked breakdown of phosphatidylinositol gives 
not only IP3 but also diacylglycerol (DG) to ac- 
tivate protein kinase C (PKC) [4]. 
However, the interaction between PKC activa- 
tion and Ca2+ mobilization induced by 5-HT in 
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V$MCs has not been reported. Therefore, we in- 
vestlpted whether PKC activation by 12-0- 
tetradecanoylphorbol-13-acetate (TPA), a tumor 
promoting phorbol ester [5], affects 5-HT- 
stimulated IP production and Ca2+ mobilization in 
VSMCs. 
2. MATERIALS AND METHODS 
Dulbecco’s modified Eagle’s medium (DMEM) and fetal calf 
serum (FCS) were purchased from Flow Laboratories (Mclean, 
VA); fura- acetoxymethyl ester (AM) from Dojin Chemical 
(Kumamoto, Japan); TPA from Sigma St. Louis, MO); 
serotonin (5hydroxytryptamine creatinine sulfate) from 
Nakarai Chemical (Kyoto, Japan); ketanserine tartrate was 
donated by Janssen-Kyowa Co. (Tokyo, Japan). 
VSMCs were prepared from 9-week-old male Wistar rats by 
the method of Charnley et al. [6] were cultured and used be- 
tween 11th and 25th passage as reported [7]. 
2.1. Measurement of inositol phosphate (IP) 
The VSMCs were incubated in 1 ml serum-free DMEM con- 
taining 5pCi myo-[‘HI inositol (spec. act.; 54.5 Ci/mmol; New 
England Nuclear. Boston, MA) for 2-3 days. After washing 
with Hepes-buffered physiological salt solution (PSS: 130 mM 
NaCI, 5 mM KCl, 1 mM MgCIz, 1.5 mM CaC12, 20 mM Hepes, 
pH 7.4), cells were preincubated at 37°C for 10 min with PSS 
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containing 10 mM LiCI. VSMCs were usually incubated with 
5-HT at 37’C for 30 s, during which time interval the maximal 
stimulation of both IP3 production and [Ca”], occurred. The 
reaction was terminated by the addition of 1 ml of 15% 
trichloroacetic acid (TCA). The TCA extract was neutralized by 
1 N NaOH and subjected to an anion-exchange resin (Dowex 
1-X8, formate form; Dow Chemical, Midland, Ml) column to 
separate total IPs by the method of Berridge et al. [8]. 
2.2. Measurement of @+I, 
After incubation in serum-free medium for 24-48 h, dis- 
persed cells were incubated at 37°C for 20 min in PSS with 4 
pM fura- AM. After loading, cells were washed and suspended 
in PSS at the concentration of - 2 x lo6 cells/ml. 
Fluorescence was measured at 37°C with Hitachi MPF-4 spec- 
trofluorimeter (excitation, 340 nm and 380 nm, slit, 5.5 nm; 
emission, 505 nm, slit, 4.5 nm) equipped with a thermostated 
cuvette holder, stirring apparatus and chart recorder. [Ca”]i 
values were calculated as described [9]. 
3. RESULTS 
5-HT dose-dependently (1 0e6- 1 Om4 M) induced 
immediate and transient increases in both IP3 pro- 
duction and [Ca’+]i (fig.l), of which effects were 
completely blocked by the 5-HTz-receptor an- 
tagonist, ketanserine (not shown); there is a close 
correlation (r = 0.943, p< 0.001) between [Ca’+]i 
and total IPs accumulated in response to S-HT. 
Fig.2. depicts representative tracings of 5-HT- 
induced fluorescence changes of fura-2-loaded 
VSMCs without or with brief (3 min) pretreatment 
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Fig. 1. Correlation between accumulation of total inositol 
phosphates (IP) and [Ca2’], in response to serotonin (5-HT). 
Cultured VSMCs were unstimulated (1) or stimulated by 1O-6 
M (2), lo-’ M (3), 10m4 M (4) 5-HT. Total IPs accumulated and 
[Ca*‘Ji are indicated on the abscissa and ordinate, respectively. 
Values are expressed as means of three experiments; bar shows 
SE. 
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Fig.2. Effect of TPA on 5-HT-stimulated increase in [Ca”],. 
Fura-2-loaded VSMCs were pretreated without (A) or with 
8 x lo-* M TPA for 3 min (B) and exposed to 10m5 M 5-HT. 
Each panel represents a typical fluorescence tracing. Calculated 
values for [Ca”], are indicated at the left. 
with 8 x lo-’ M TPA. In control cells, lo-’ M 
5-HT caused a rapid increase in [Ca’+]i, followed 
by a gradual decline to a sustained phase still 
higher than the prestimulation level (fig.2A), while 
pretreatment with TPA had no effect on resting 
[Ca’+]i, but markedly attenuated the 5-HT- 
induced [Ca’+]i transient. 
Table 1 summarizes the effect of TPA on 5-HT- 
induced increases in total IP formation and 
[Ca’+]i. TPA significantly @<0.05) attenuated 
5-HT-stimulated accumulation of total IPs and the 
[Ca’+]i, transient without affecting their basal 
levels. 
Table 1 
Effect of TPA on 5-HT-stimulated accumulation of total in- 
ositol phosphates (1P) and [Ca”]; 
Drug (M) [Ca”l, (nM) 1Ps (cpm) 
Control 126 + 33 (9) 2524 + 79 (3) 
TPA 
(8 x lo-‘) 128 * 7.8 (3) 
1 1 
+ 2647 f 295 (3) *** 
5-HT 
(10-S) 187 f 6.2 (3) 3152 i 118 (3) 
TPA 
(8 x 1O-8) 
** 
1 1 
** 
+ 5-HT 
(lo-’ M) 157 _+ 12.4 (3) 2817 f 116 (3) 
VSMCs were incubated in the absence or presence of 10m5 M 
5-HT. 8 x lo-’ M TPA and 5-HT plus TPA. Values of IP and 
[Ca”], are expressed as means f SE; in parentheses the 
number of samples tested is given. Asterisks show statistically 
significant differences between groups as indicated by arrows: 
*, p<O.OOl; **, p<o.o05; ***, p<o.oos 
229 
Volume 234, number 1 FEBS LETTERS July 1988 
4. DISCUSSION 
Endogenous vasoconstrictors, including 5-HT, 
norepinephrine, angiotensin II and arginine- 
vasopressin, induce phospholipase C-mediated 
PIP2 hydrolysis through their specific receptors 
[3,10-121. IP3 and DG, two main products 
generated by PIP2 breakdown, serve as putative 
second messengers for Ca2+ mobilization and PKC 
activation, respectively, and they act synergistical- 
ly in a variety of cells, thus leading to positive 
physiological responses, such as hormone secretion 
and exocytosis of enzymes from endocrine and ex- 
ocrine cells and cellular proliferation [4]. Recent 
evidence suggests that PKC activated by adrenergic 
au-agonist and angiotensin II exerts negative feed- 
back control on the receptors for these agonists in 
hepatocytes [13] or smooth muscle cells [14]. 
The present results show that pretreatment with 
TPA, a phorbol ester substituting for endogenous 
DC, presumably acting through stimulation of 
PKC, leads to inhibition of 5-HT-induced in- 
creases of both [Ca”]i and IP formation without 
affecting their basal levels, suggesting the possible 
involvement of PKC in the mechanism of 
5-HTz-mediated PI response and mobilization of 
intracellular Ca2+ in VSMCs. It has recently been 
shown that TPA inhibits IP formation and/or in- 
creases in [Ca2+]i stimulated by AI1 [14] and 
norepinephrine 1151, without any changes of these 
receptors in cultured VSMCs. In contrast, it has 
been demonstrated that phorbol esters cause 
phosphorylation of ai-adrenergic receptors in 
DDT MF-2 cells, a clonal cell line derived from 
hamster vas deferens smooth muscle cells, thereby 
uncoupling the receptor from phospholipase C ac- 
tivation [16]. However, it remains unknown 
whether PKC phosphorylates the 5-HT2 receptor 
to uncouple the receptor from phosphoinositide 
metabolism to account for the observed TPA- 
induced attenuation of IP formation and [Ca’+]i 
by 5-HT. 
On the other hand, it has been demonstrated 
that pertussis toxin, that ADP-ribosylates the CY- 
subunit of GTP-binding protein [17], attenuates 
the IP3-mediated increases in [Ca2+]i induced by 
fMet-Leu-Phe and leukotriene B4 [ 181 through the 
inhibition of the polyphosphoinositide breakdown 
by these agents in rabbit neutrophils [19], and that 
pertussis toxin-sensitive G-protein is phosphory- 
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lated by PKC in human platelets [20]. More recent 
study has shown that pertussis toxin inhibits 5-HT- 
induced increases of [Ca2+]i in cultured VSMCs 
[21]. Therefore, it is possible to speculate that G- 
protein may also be involved in the mechanism of 
TPA-induced attenuation of IP production and 
[Ca2+]i stimulated by 5-HT as observed in the pre- 
sent study. 
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